Bridgeway Capital Management’s NovaBay Pharmaceuticals NBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-127
| Closed | -$17K | – | 1429 |
|
|
2022
Q3 | $17K | Hold |
127
| – | – | ﹤0.01% | 1396 |
|
|
2022
Q2 | $39K | Hold |
127
| – | – | ﹤0.01% | 1298 |
|
|
2022
Q1 | $46K | Hold |
127
| – | – | ﹤0.01% | 1293 |
|
|
2021
Q4 | $58K | Hold |
127
| – | – | ﹤0.01% | 1240 |
|
|
2021
Q3 | $100K | Hold |
127
| – | – | ﹤0.01% | 1251 |
|
|
2021
Q2 | $104K | Sell |
127
-138
| -52% | -$113K | ﹤0.01% | 1311 |
|
|
2021
Q1 | $296K | Buy |
265
+245
| +1,225% | +$274K | 0.01% | 1223 |
|
|
2020
Q4 | $17K | Hold |
20
| – | – | ﹤0.01% | 1301 |
|
|
2020
Q3 | $18K | Hold |
20
| – | – | ﹤0.01% | 1311 |
|
|
2020
Q2 | $29K | Hold |
20
| – | – | ﹤0.01% | 1284 |
|
|
2020
Q1 | $15K | Hold |
20
| – | – | ﹤0.01% | 1257 |
|
|
2019
Q4 | $16K | Hold |
20
| – | – | ﹤0.01% | 1297 |
|
|
2019
Q3 | $15K | Buy |
+20
| New | +$15K | ﹤0.01% | 1301 |
|
|
2014
Q3 | – | Sell |
-4
| Closed | -$96K | – | 1511 |
|
|
2014
Q2 | $96K | Hold |
4
| – | – | ﹤0.01% | 1401 |
|
|
2014
Q1 | $142K | Hold |
4
| – | – | ﹤0.01% | 1367 |
|
|
2013
Q4 | $149K | Hold |
4
| – | – | ﹤0.01% | 1330 |
|
|
2013
Q3 | $209K | Hold |
4
| – | – | 0.01% | 1309 |
|
|
2013
Q2 | $168K | Buy |
+4
| New | +$168K | 0.01% | 1300 |
|